Development of a self‐management education module for those with type 2 diabetes on injectable therapies

Abstract The number of people using injectable therapies in the UK has dramatically increased over the last 20 years. People using insulin require intense support from health care professionals (HCPs). This paper describes a module which was developed for people with type 2 diabetes being treated with injectable therapies to empower them to effectively self‐manage their treatment. This was based on evidence from a previously published randomised controlled trial (the Microalbuminuria Education and Medication Optimisation [MEMO] study). Groups of up to 10 participants (with partners) are invited to attend a core session (either insulin or GLP‐1 therapy) lasting 3.5 hours and then attend five topic‐specific sessions (2.5 hours). Participants choose to attend all or some of these topic sessions allowing for maximum flexibility for self‐management plans. Participants are encouraged at the end of each session to work with the HCP facilitator to suggest changes to their treatment regimens if required. It is recommended that participants attend a basic structured diabetes education programme before commencing the programme. Facilitators are trained HCPs due to the skills, knowledge and expertise needed in treatment adjustments. A pilot was conducted (participants n = 9) which showed positive evaluations from both facilitators and participants. The module toolkit contains a curriculum, resources and a participant workbook, and workshop training is provided. The programme is c...
Source: Practical Diabetes - Category: Endocrinology Authors: Tags: Practice point Source Type: research